YM150

Phase 1Completed

0 views this week 0 watching💤 Quiet

Interest: 29/100

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Healthy Volunteer

Conditions

Healthy Volunteer, Pharmacokinetics of YM150

Trial Timeline

Feb 1, 2010 → Mar 1, 2010

NCT ID

NCT01125657

About YM150

YM150 is a phase 1 stage product being developed by Astellas Pharma for Healthy Volunteer. The current trial status is completed. This product is registered under clinical trial identifier NCT01125657. Target conditions include Healthy Volunteer, Pharmacokinetics of YM150.

What happened to similar drugs?

20 of 20 similar drugs in Healthy Volunteer were approved

Approved (20) Terminated (1) Active (0)

✅mRNA-1273.712ModernaApproved

✅Cholestyramine + Colesevelam HClDaiichi SankyoApproved

✅Cholestyramine + Cholestyramine + TangDaiichi SankyoApproved

✅Olmesartan medoxomil + Irbesartan + ValsartanDaiichi SankyoApproved

✅Perampanel 6 MGEisaiApproved

✅eszopiclone, zolpidem, placeboSumitomo PharmaApproved

✅Listerine Experimental Mouthwash + Colgate Cavity Protection Toothpaste + Listerine Total Care ZeroJohnson & JohnsonApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (9)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01125670	Phase 1	Completed	Feb 1, 2010	Apr 1, 2010	Healthy Volunteer
NCT01125657	Phase 1	Completed	Feb 1, 2010	Mar 1, 2010	Healthy Volunteer
NCT01118559	Phase 1	Completed	Nov 1, 2009	Jan 1, 2010	Healthy
NCT00937820	Phase 3	Completed	Jun 1, 2009	Dec 1, 2010	Venous Thromboembolism
NCT00937911	Phase 3	Completed	Jun 1, 2009	Apr 1, 2010	Venous Thromboembolism
NCT00942435	Phase 3	Completed	Jun 1, 2009	Apr 1, 2010	Venous Thromboembolism
NCT01028950	Phase 3	Completed	May 1, 2009	Apr 1, 2010	Venous Thromboembolism
NCT01657981	Phase 1	Completed	Feb 1, 2007	Mar 1, 2007	Pharmacokinetics
NCT00353678	Phase 2	Completed	Jun 1, 2006	Aug 1, 2007	Thromboembolism

Competing Products

20 competing products in Healthy Volunteer

See all competitors

Product	Company	Stage	Hype Score
Use of Wearable Digital Sensors After mRNA Vaccination in Adults	Moderna	Preclinical	0
mRNA-0184	Moderna	Phase 1	0
mRNA-6231	Moderna	Phase 1	0
Letrozole	Dr. Reddy's Laboratories	Phase 1	26
Isotretinoin	Dr. Reddy's Laboratories	Phase 1	26
Fexofenadine	Dr. Reddy's Laboratories	Phase 1	26
Sertraline	Dr. Reddy's Laboratories	Phase 1	26
Nizatidine + Axid	Dr. Reddy's Laboratories	Phase 1	26
Anastrozole	Dr. Reddy's Laboratories	Phase 1	26
mRNA-1273.712	Moderna	Approved	0
Risperidone	Dr. Reddy's Laboratories	Phase 1	26
Lamotrigine	Dr. Reddy's Laboratories	Phase 1	26
Metformin + Glucophage	Dr. Reddy's Laboratories	Phase 1	26
Lamotrigine	Dr. Reddy's Laboratories	Phase 1	26
mRNA-0184	Moderna	Phase 1	0
Divalproex Sodium	Dr. Reddy's Laboratories	Phase 1	26
Sirolimus	Dr. Reddy's Laboratories	Phase 1	26
Glimepiride	Dr. Reddy's Laboratories	Phase 1	26
Ziprasidone Hydrochloride	Dr. Reddy's Laboratories	Phase 1	26
Naproxen sodium	Dr. Reddy's Laboratories	Phase 1	26